Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Amortizatization of Intangibles (2024 - 2025)

Historic Amortizatization of Intangibles for Zevra Therapeutics (ZVRA) over the last 2 years, with Q3 2025 value amounting to $1.2 million.

  • Zevra Therapeutics' Amortizatization of Intangibles changed N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $890000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Zevra Therapeutics' Amortizatization of Intangibles stood at $1.2 million.
  • Over the past 5 years, Zevra Therapeutics' Amortizatization of Intangibles peaked at $1.2 million during Q3 2025, and registered a low of $305000.0 during Q1 2025.